Xenon shares get Buy nod from H.C. Wainwright, price target unchanged

XENE Stock  USD 38.52  1.10  2.78%   
About 61% of Xenon Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Xenon Pharmaceuticals suggests that many traders are alarmed. The current market sentiment, together with Xenon Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Xenon Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  
Xenon shares get Buy nod from H.C. Wainwright, price target unchanged

Read at investing.com
Investing News at Macroaxis
  

Xenon Pharmaceuticals Fundamental Analysis

We analyze Xenon Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Xenon Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Xenon Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned By Insiders

Shares Owned By Insiders Comparative Analysis

Xenon Pharmaceuticals is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Xenon Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Xenon Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Xenon Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Xenon Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Xenon Pharmaceuticals Related Equities

REPLReplimune   16.86   
0%
100.0%
VTYXVentyx Biosciences   6.88   
0%
40.0%
ANABAnaptysBio   6.50   
0%
38.0%
VRDNViridian Therapeutics   6.27   
0%
37.0%
MGTXMeiraGTx Holdings   5.56   
0%
32.0%
IDYAIdeaya Biosciences   4.37   
0%
25.0%
CRNXCrinetics Pharmaceuticals   3.78   
0%
22.0%
PCVXVaxcyte   3.36   
0%
19.0%
KROSKeros Therapeutics   3.23   
0%
19.0%
UTHRUnited Therapeutics   2.52   
0%
14.0%
ASNDAscendis Pharma   2.29   
0%
13.0%
MRUSMerus BV   0.74   
0%
4.0%
CYTKCytokinetics   0.17   
0%
1.0%
ACLXArcellx   0.14   
0%
1.0%
NUVLNuvalent   0.20   
1.0%
0%
INBXInhibrx   0.37   
2.0%
0%
LYELLyell Immunopharma   1.72   
10.0%
0%
EWTXEdgewise Therapeutics   1.72   
10.0%
0%
KRONKronos Bio   1.98   
11.0%
0%
DYNDyne Therapeutics   4.33   
25.0%
0%

Complementary Tools for Xenon Stock analysis

When running Xenon Pharmaceuticals' price analysis, check to measure Xenon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xenon Pharmaceuticals is operating at the current time. Most of Xenon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Xenon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xenon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Xenon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bonds Directory
Find actively traded corporate debentures issued by US companies
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Money Managers
Screen money managers from public funds and ETFs managed around the world
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios